CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers

被引:38
|
作者
Jin, Chuan [1 ]
Ma, Jing [1 ]
Ramachandran, Mohanraj [1 ]
Yu, Di [1 ]
Essand, Magnus [1 ]
机构
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
NEUTROPHIL-ACTIVATING PROTEIN; CHIMERIC ANTIGEN RECEPTOR; IMMUNOTHERAPY; INFILTRATION; LYMPHOCYTES; EFFICACY; SURVIVAL; THERAPY;
D O I
10.1038/s41551-022-00875-5
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Chimeric antigen receptor T cells (CAR T cells) are effective against haematologic malignancies. However, in solid tumours, their potency is hampered by local immunosuppression and by the heterogeneous expression of the antigen that the CAR targets. Here we show that CAR T cells expressing a pluripotent pro-inflammatory neutrophil-activating protein (NAP) from Helicobacter pylori trigger endogenous bystander T-cell responses against solid cancers. In mice with subcutaneous murine pancreatic ductal adenocarcinomas, neuroblastomas or colon carcinomas, CAR(NAP) T cells led to slower tumour growth and higher survival rates than conventional mouse CAR T cells, regardless of target antigen, tumour type and host haplotype. In tumours with heterogeneous antigen expression, NAP secretion induced the formation of an immunologically 'hot' microenvironment that supported dendritic cell maturation and bystander responses, as indicated by epitope spreading and infiltration of cytotoxic CD8(+) T cells targeting tumour-associated antigens other than the CAR-targeted antigen. CAR T cells armed with NAP neither increased off-tumour toxicity nor hampered the efficacy of CAR T cells, and hence may have advantageous translational potential. T cells expressing a pluripotent pro-inflammatory neutrophil-activating protein from Helicobacter pylori trigger endogenous bystander T-cell responses against solid cancers.
引用
收藏
页码:830 / 841
页数:25
相关论文
共 50 条
  • [1] CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
    Chuan Jin
    Jing Ma
    Mohanraj Ramachandran
    Di Yu
    Magnus Essand
    Nature Biomedical Engineering, 2022, 6 : 830 - 841
  • [2] Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
    Rossig, Claudia
    Kailayangiri, Sareetha
    Jamitzky, Silke
    Altvater, Bianca
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [3] Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
    Kyte, Jon Amund
    CANCERS, 2022, 14 (03)
  • [4] CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
    Fu, Wenyan
    Lei, Changhai
    Liu, Shuowu
    Cui, Yingshu
    Wang, Chuqi
    Qian, Kewen
    Li, Tian
    Shen, Yafeng
    Fan, Xiaoyan
    Lin, Fangxing
    Ding, Min
    Pan, Mingzhu
    Ye, Xuting
    Yang, Yongji
    Hu, Shi
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [5] CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
    Wenyan Fu
    Changhai Lei
    Shuowu Liu
    Yingshu Cui
    Chuqi Wang
    Kewen Qian
    Tian Li
    Yafeng Shen
    Xiaoyan Fan
    Fangxing Lin
    Min Ding
    Mingzhu Pan
    Xuting Ye
    Yongji Yang
    Shi Hu
    Nature Communications, 10
  • [6] RORing CAR T Cells in Solid and Hematologic Cancers: Same but Different
    Kobold, Sebastian
    CLINICAL CANCER RESEARCH, 2025, 31 (03) : 437 - 438
  • [7] CONTEXTUAL REPROGRAMMING OF CAR T CELLS FOR THE TREATMENT OF HER2-EXPRESSING CANCERS
    Yang, Zhifen
    Li, Lingyu
    Turkoz, Ahu
    Chen, Pohan
    Choi, Hana
    Inel, Damla
    Qi, Stanley
    Marincola, Francesco
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A86 - A87
  • [8] Super2-expressing CAR T cells generate improved anti-tumor responses against solid tumors
    Brog, Rachel A.
    Kumar, Prathna
    Sentman, Charles
    Huang, Yina
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [9] Eradication of EpCAM expressing solid tumors by low-affinity CAR T cells
    Yang, Yanping
    McCloskey, Jaclyn E.
    Yang, Huan
    Puc, Janusz
    Gallegos, Angel A. Gomez
    Vedvyas, Yogindra
    Min, Irene M.
    von Hofe, Eric
    Jin, Moonsoo M.
    CANCER RESEARCH, 2020, 80 (16)